ADA Scientific Sessions – The Second Day: Andrew Rakeman, Ph.D.
We’re at the 2019 American Diabetes Association Scientific Sessions, and there’s so much to learn! Here is the recap from Breakthrough T1D‘s assistant director for science, Andy Rakeman, Ph.D.:
Sanjoy Dutta, Ph.D.: The Beginning of the ADA Scientific Sessions
The ADA’s Scientific Sessions has begun! Here, in the first recap, is Sanjoy Dutta, Ph.D., who highlights beta cell replacement therapies. Happy viewing!
Breakthrough T1D Heads to ADA’s 79th Scientific Sessions
The American Diabetes Association’s (ADA) 79th Scientific Sessions is almost here! From June 7-11, in San Francisco, CA, scientists and healthcare professionals will gather at one of the largest conferences of diabetes researchers in the world. Breakthrough T1D researchers and Breakthrough T1D-funded scientists will also be there to hear first-hand and present new study results […]
Breakthrough T1D Expresses Profound Loss at the Passing of Helaine Shiff, co-founder of Breakthrough T1D Canada
Breakthrough T1D International is deeply saddened at the loss of one of Breakthrough T1D Canada’s co-founders, Helaine Shiff. “Helaine was a remarkable woman and her legacy to our community will live on forever,” said Dave Prowten, President and CEO of Breakthrough T1D Canada. “She never let up and continued to the very end to help […]
A Win for the European T1D Community: Zynquista (sotagliflozin) Approved for Type 1 Diabetes
In a second win for the type 1 diabetes (T1D) community, the European Commission has approved Zynquista™ (sotagliflozin) for use in adults with T1D with a body mass index (BMI) above or equal to 27 kg/m2, in combination with insulin to improve blood-sugar control. It and Forxiga® (dapagliflozin and marketed in the United States as […]
Breakthrough T1D Names Aaron Kowalski New President and CEO
Chief Mission Officer to assume leadership baton from Derek Rapp After a thorough national search, the Breakthrough T1D International Board of Directors has unanimously voted on and approved the appointment of Aaron J. Kowalski, Ph.D., to serve as its new President and CEO, leading Breakthrough T1D’s race to cure type 1 diabetes and to improve […]
Breakthrough T1D Nurtures the Young Adult Community by Hosting Networking Conference and Helping Secure Key Internships
More than 120 Young Adults joined Breakthrough T1D for a weekend of networking, learning and connecting at the Breakthrough T1D Young Adult Conference held in Dallas, Texas on March 30 and 31. Find the photos of this electrifying conference here. The conference experience was enriched by speakers who inspired our participants by talking about living […]
Breakthrough T1D Leaders Jeff Plumer and Sanjoy Dutta Join Editorial Advisory Boards of Two Top Diabetes Publications
Two of the world’s most respected and trusted health publications have tapped Breakthrough T1D to serve as an expert voice on their advisory panels. Breakthrough T1D IBOD Vice-Chair Jeff Plumer joins the editorial advisory board of Diabetes Self-Management, an award-winning magazine with more than 7 million readers and has claimed nearly 400 awards of excellence […]
Testimony of Dr. Aaron Kowalski, Chief Mission Officer, Breakthrough T1D House Energy & Commerce Committee Oversight And Investigations Subcommittee
‘PRICED OUT OF A LIFESAVING DRUG: THE HUMAN IMPACT OF RISING INSULIN COSTS’ Chairwoman DeGette, Ranking Member Guthrie, Chairman Pallone, Ranking Member Walden and Members of the Subcommittee — thank you for the spotlight you are placing on the issue of insulin affordability. In 1977, my younger brother Stephen was diagnosed with type 1 diabetes. […]
Insulin pumps, CGMs and more: is T1D Tech right for you?
Hear from six people living with T1D about their #T1DTech, the fears they had before using their various devices, and how these options have changed their life with T1D.
